3 Health investors share their most controversial industry

Health investors are increasingly interested in financing companies focused on specialized pharmacy, women’s health, patient experience and more, according to a Tuesday panel of three ventilation capital from Medcity Invest Conference in Chicago.

However, some areas in health investors are trying to distance themselves. During the round table, the moderator David Kereiakes, managing manner of Windham Capital Partners, asked VC panelists their controversial version of the industry. Here is what they said:

Should each startup be fed by AI?

One of the panelists, Aman Shah, vice-president of New Ventures at VNS Health, noted that almost all the pitch terrains he sees is for AI these days, which, according to him, was not entirely necessary.

“Should each company be an AI company? … When I started with companies earlier, as if there were no AI companies, and 24 months take place now,” we are fed by AI “. And I say to myself, “Are you really fueled by AI? And I’m not smart enough to determine if these models are really good,” he said.

He added that companies should first focus on creating a good business, then they can work on the use of AI to improve this business. But you don’t have to use AI to succeed.

There is no longer a lot of new things to build

The way companies start to change now, according to Dipa Mehta,

Director Partner of Valeo Ventures. Previously, it was that startups would identify a problem and a way to solve it, then build technology and sell it to customers.

However, nowadays, “health care and technology are at a time when there are not much new things to do,” said Mehta.

“Where I saw the most success now is to create companies with customers rather than trying to create something by themselves,” she said. “If you are an entrepreneur in the room with very good ideas, it could be a really interesting starting point because I think it is really difficult to start new innovative companies in technology and health care at the moment.”

Value -based care is not all

The health care industry is trying to move away from the reacting and the value -based care. However, another panelist, Raffi Boyajian, investor / director of Cigna Ventures, argued that value -based care is not the “Saint Grail”, in particular for businesses at an early stage.

“If you start to move on to this, you can get your contracts very, very quickly in terms of financial perspective. Or what is happening, you find success, you must increase even more capital, management teams, employees, they are already diluted. So I think it’s a big idea.